3 hours Kura Oncology (NASDAQ:KURA) Receives “Buy” Rating from HC WainwrightMarketBeat
HC Wainwright reiterated a “buy” rating and issued a $32.00 target price on shares of Kura Oncology in a research note on Thursday.
XHC Wainwright reiterated a “buy” rating and issued a $32.00 target price on shares of Kura Oncology in a research note on Thursday.
X